Upgrade to SI Premium - Free Trial

Olema Pharmaceuticals (OLMA) PT Lowered to $38 at H.C. Wainwright

March 9, 2026 11:59 AM
H.C. Wainwright analyst Emily Bodnar lowered the price target on Olema Pharmaceuticals (NASDAQ: OLMA) to $38.00 (from $45.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change